ARTICLE | Company News
Millennium and Aventis close deal
July 28, 2000 7:00 AM UTC
The companies completed their agreement to jointly develop drugs for inflammation and discovery technologies. As a result, AVE has made a $150 million stock purchase in MLNM (see BioCentury, July 26)...